A. Lanzilli
University of Naples Federico II
3 Papers
13 Citations
A. Lanzilli is an academic researcher from University of Naples Federico II. The author has contributed to research in topics: Framingham Risk Score & Internal medicine. The author has an hindex of 1, co-authored 1 publications.
Chat about Author
Papers
The number of risk factors not at target is associated with cardiovascular risk in a type 2 diabetic population with albuminuria in primary cardiovascular prevention. Post-hoc analysis of the NID-2 trial
Vittorio Simeon,Raffaele Galiero,Alfredo Caturano,Paolo Chiodini,Luca Rinaldi,Teresa Salvatore,Miriam Lettieri,Riccardo Nevola,Celestino Sardu,Giovanni Docimo,Giuseppe Loffredo,Raffaele Marfella,Luigi Elio Adinolfi,U. Amelia,Carlo Acierno,P. Calatola,Ornella Carbonara,Giuseppe Conte,G. Corigliano,Marco Corigliano,R. D’urso,Antonia De Matteo,Luca De Nicola,N. De Rosa,Elisa Del Vecchio,Giacomo Di Giovanni,A. Gatti,Sandro Gentile,L. Gesuè,L Improta,A. LampitellaJr,A. Lampitella,A. Lanzilli,Nadia Lascar,S. Masi,Paola Mattei,V. Mastrilli,P. Memoli,Roberto Minutolo,Rodolfo Nasti,Andrew Pagano,M. Pentangelo,Edoardo Pisa,Emiliano Rossi,Ferdinando Carlo Sasso,Sabato Sorrentino,Roberto Torella,R. Troise,Paolo Trucillo,A.A. Turco,Salvatore Turco,Francesco Zibella,Laura Zirpoli +52 more
TL;DR: In this article , a post-hoc analysis of the Nephropathy in Diabetes type 2 (NID-2) study is presented, where the authors evaluate whether the number of risk factors on target associates with patient outcomes.
Reduced cold-induced thermogenesis in familial human obesity.
TL;DR: It is concluded that cold-induced thermogenesis is impaired in familial early-onset human obesity and in genetically obese mice.
14
Sex-difference of multifactorial intervention on cardiovascular and mortality risk in DKD: post-hoc analysis of a randomised clinical trial
Roberto Minutolo,V. Simeon,Luca De Nicola,Paolo Chiodini,Raffaele Galiero,L. Rinaldi,Alfredo Caturano,Erica Vetrano,Celestino Sardu,Raffaele Marfella,Ferdinando Carlo Sasso,U. Amelia,C. Acierno,P. Calatola,Ornella Carbonara,Alfredo Caturano,G. Conte,G. Corigliano,Marco Corigliano,R. D’urso,A. De Matteo,Luca De Nicola,N. De Rosa,Elisa Del Vecchio,Gianluca Di Giovanni,A. Gatti,S. Gentile,L. Gesuè,L Improta,A. Lampitella Jr,A. Lampitella,A. Lanzilli,Nadia Lascar,S. Masi,P. Mattei,V. Mastrilli,P. Memoli,Roberto Minutolo,Rodolfo Nasti,Andrew Pagano,M. Pentangelo,Edoardo Pisa,E. Rossi,Ferdinando Carlo Sasso,S. Sorrentino,R. Torella,R. Troise,P. Trucillo,A.A. Turco,Salvatore Turco,Francesco Zibella,Laura Zirpoli +51 more
TL;DR: A post-hoc analysis of a randomized clinical trial found that intensive multifactorial therapy reduced cardiovascular and mortality risk by 52% in women and 44% in men with type 2 diabetes, with a greater survival advantage in women.